Orr J W, Holloway R W, Orr P F, Holimon J L
Department of Gynecology and Obstetrics, Watson Clinic, Lakeland, Florida 33805.
Gynecol Oncol. 1991 Sep;42(3):209-16. doi: 10.1016/0090-8258(91)90347-8.
Surgical staging documented extrauterine disease in 27.9% of 168 patients with apparent early-clinical-stage uterine cancer. An analysis of operative time (78 +/- 21 min), blood loss (332 +/- 160 cc), and surgical site infection risks (4.7%) indicated little additional risk of lymphadenectomy. The long-term risk of lymphocyst (1.3%) or lymphedema (0.7%) was small. The histologic information obtained from staging was utilized to rationally guide the need for adjunctive teletherapy. The overall risk of recurrence (median follow-up, 26 months) with surgical Stage I disease was 2.6%.
